Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Anhui Anke Biotechnology (Group) (300009 CH)
Watchlist
16
Analysis
Health Care
•
China
Anhui Anke Biotechnology (Group) Company Ltd. develops, manufactures and markets pharmaceuticals and health-care products including genetic and cellular engineering research and products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Changchun High & New Tech A
•
16 Aug 2021 09:08
Changchun High & New Tech (000661.CH) - Logic Change?
The article analyzed Changchun High & New Tech in terms of its 2021/1H financial results,media exposure of growth hormone abuse, possibility of...
Xinyao (Criss) Wang
Follow
173 Views
Share
bearish
•
Thematic (Sector/Industry)
•
25 Jul 2021 09:02
China Healthcare Weekly (July.23)
The article analyzed the supporting measures for the three-child policy, the mainstay position of public hospitals, the new DIP regulation...
Xinyao (Criss) Wang
Follow
255 Views
Share
bullish
•
I-Mab
•
29 Mar 2021 09:05
I-Mab (IMAB US) - Insights On Core Products TJC4, TJ202 and TJ101
As I-MAB has come to a key phase from R&D to commercialization, this article analyzed both the strength and the concerns for its core products...
Xinyao (Criss) Wang
Follow
213 Views
Share
bullish
•
Shanghai Henlius Biotech
•
21 Aug 2019 02:46
Shanghai Henlius Biotech IPO Initiation: Going Large
Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...
Arun George
Follow
648 Views
Share
bearish
•
Shanghai Henlius Biotech
•
19 Feb 2019 01:24
HLX02: Innovation Could Overtake
The oncology treatment landscape in China is evolving rapidly as the government has prioritized access to innovative drugs to meet this significant...
Kemp Dolliver, CFA
485 Views
Share
Previous
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x